Retaglutide is a novel GLP-1 receptor agonist currently under investigation for the management of type 2 diabetes. This medication works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally https://berthaknae444774.blogvivi.com/39638470/retaglutide-a-promising-glp-1-receptor-agonist